XML 20 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenues:      
Premiums $ 158,453 $ 144,118 $ 127,163
Products 26,366 26,658 17,312
Services 15,317 13,236 11,922
Investment and other income 1,023 828 710
Total revenues 201,159 184,840 157,107
Operating costs:      
Medical costs 130,036 117,038 103,875
Operating costs 29,557 28,401 24,312
Cost of products sold 24,112 24,416 16,206
Depreciation and amortization 2,245 2,055 1,693
Total operating costs 185,950 171,910 146,086
Earnings from operations 15,209 12,930 11,021
Interest expense (1,186) (1,067) (790)
Earnings before income taxes 14,023 11,863 10,231
Provision for income taxes (3,200) (4,790) (4,363)
Net earnings 10,823 7,073 5,868
Earnings attributable to noncontrolling interests (265) (56) (55)
Net earnings attributable to UnitedHealth Group common shareholders $ 10,558 $ 7,017 $ 5,813
Earnings per share attributable to UnitedHealth Group common shareholders:      
Basic $ 10.95 $ 7.37 $ 6.10
Diluted $ 10.72 $ 7.25 $ 6.01
Basic weighted-average number of common shares outstanding 964 952 953
Dilutive effect of common share equivalents 21 16 14
Diluted weighted-average number of common shares outstanding 985 968 967
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 5 3 8
Cash dividends declared per common share $ 2.875 $ 2.375 $ 1.875